The Hepatitis A & B Titer Test Panel is a comprehensive diagnostic tool designed to evaluate an individual's immunity status or infection presence for Hepatitis A and Hepatitis B viruses. This panel combines serological assays that measure specific antibodies and antigens associated with Hepatitis A and B, providing crucial insights for clinical diagnosis, vaccination verification, and the assessment of immune response post-vaccination or post-exposure.

 The Hepatitis B Titer Test Panel is a diagnostic panel that comprises three essential tests designed to assess immunity, infection status, and antibody levels for the Hepatitis B virus (HBV). The panel includes the following tests: Hepatitis B Core Antibody Total, Hepatitis B Surface Antibody Quantitative, and Hepatitis B Surface Antigen with Reflex Confirmation.

The Hepatitis B Core Antibody Total Test is a qualitative blood test that detects antibodies to the hepatitis B core antigen (anti-HBc) and reports results as Reactive or Non-Reactive. A reactive result may indicate past or ongoing infection, while a non-reactive result suggests no exposure. This test does not distinguish between IgM and IgG antibodies. Doctors use it to evaluate hepatitis B exposure, confirm infection history, and assess overall immune response.

The Hepatitis B Surface Antibody Quantitative Test measures the exact level of anti-HBs antibodies in blood to determine past exposure and whether protective immunity has developed from infection or vaccination. A higher antibody level generally indicates adequate immune response, while a low level suggests limited or no protection. Doctors use this test to confirm vaccine effectiveness, assess immune status, and support hepatitis B screening or preventive care.

The Hepatitis B Surface Antibody Qualitative Test detects anti-HBs antibodies to the hepatitis B surface antigen and reports results as Reactive or Non-Reactive. A reactive result indicates past exposure, either from hepatitis B infection or prior vaccination, while a non-reactive result suggests no detectable exposure. Doctors use this test to confirm hepatitis B exposure history, evaluate vaccine response, and guide further preventive or diagnostic decisions.

The Hepatitis B Core IgM Antibody Test is a qualitative test that detects IgM antibodies to the hepatitis B core antigen (anti-HBc IgM) and reports results as Reactive or Non-Reactive. A reactive result indicates a recent or acute hepatitis B infection, while a non-reactive result suggests no active infection. Doctors order this test to confirm acute hepatitis B in patients with symptoms such as jaundice, fatigue, fever, or abdominal pain and to guide treatment and monitoring.

The Hepatitis B Immunity Panel Test evaluates immune status by measuring Hepatitis B surface antibody levels in the blood. A positive result typically indicates immunity from vaccination or past infection, while a negative result suggests susceptibility. This test is important for verifying protection, monitoring vaccine response, or determining if additional vaccination or further evaluation for Hepatitis B exposure is needed.

The Hepatitis B Core Antibody Total Test with Reflex to IgM detects antibodies (anti-HBc) to the hepatitis B core antigen. If the total antibody test is reactive, reflex testing determines if IgM antibodies are present, which indicates recent or acute infection. A reactive total with non-reactive IgM suggests past or chronic infection. Doctors use this test to confirm exposure, distinguish acute from prior infection, and support hepatitis B screening and diagnosis.

The Hepatitis B Virus DNA Quantitative Test measures the amount of HBV genetic material in blood to determine viral load. This test helps evaluate disease activity, monitor progression of acute or chronic hepatitis B, and assess treatment response. High viral load indicates active replication, while low or undetectable levels suggest controlled infection. Doctors use it to guide antiviral therapy, track treatment effectiveness, and manage long-term liver health.

The Hepatitis B Test (Hepatitis B Surface Antigen with Reflex to Confirmation) screens for hepatitis B surface antigen (HBsAg) in the blood to identify active infection. If the result is positive, a confirmation test is automatically performed to verify accuracy and support proper diagnosis.

The Hepatitis B Surface Antigen (HBsAg) Test with Reflex to Confirmation screens for hepatitis B surface antigen in blood and, if reactive, automatically performs confirmatory testing. A reactive confirmed result indicates an active hepatitis B infection, while a non-reactive result shows no infection. Doctors use this test to diagnose acute or chronic hepatitis B, investigate abnormal liver tests, and guide treatment, monitoring, and infection control decisions.

 The Immunity Panel Plus is a comprehensive set of tests designed to evaluate an individual's immunity to certain infectious diseases. This panel includes tests for Hepatitis A Antibody Total, Hepatitis B Surface Antibody, Quantitative, Measles IgG Antibody, Mumps IgG Antibody, Rubella IgG Antibody, and Varicella-Zoster Virus IgG Antibody. It is often used to determine if an individual has immunity, either from previous infections or vaccinations, against these specific diseases.

The Hep B Test, a Hepatitis B Surface Antigen Test with Reflex to Confirmation, screens for active hepatitis B infection by detecting HBsAg in the blood. A reflex confirmation is performed if the initial result is positive, ensuring accuracy. Doctors use this test to diagnose current infection, monitor at-risk patients, and prevent transmission. It is essential for evaluating liver health, guiding treatment, and supporting safe medical or prenatal care.